<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<title>Robert C. Knapp, MD</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<link href="styles.css" rel="stylesheet" type="text/css">
<script language="JavaScript" type="text/JavaScript">
<!--
function MM_reloadPage(init) {  //reloads the window if Nav4 resized
  if (init==true) with (navigator) {if ((appName=="Netscape")&&(parseInt(appVersion)==4)) {
    document.MM_pgW=innerWidth; document.MM_pgH=innerHeight; onresize=MM_reloadPage; }}
  else if (innerWidth!=document.MM_pgW || innerHeight!=document.MM_pgH) location.reload();
}
MM_reloadPage(true);
//-->
</script>
</head>

<body>
<div id="statsshell">
  <div id="stats">
    <div id="imagetop">
      <img src="bknapp.jpg">
      <h1>Robert C. Knapp</h1>
    </div>
    <div id="contact">
      <p>20 Sutton Place South<br>
    New York, NY 10022<br>
    <br>

    Phone: (212) 829-1209<br>
      Fax: (212) 753-9929<br>
      <a href="email2.php" target="_blank">Email Dr. Knapp</a></p>
    </div>
 <p>Dr. Knapp is the former Director of Gynecology and Gynecologic Oncology at the
Brigham and Women's Hospital and the Dana Farber Cancer Institute.</p>
<p>Dr. Knapp's complete CV  is available as a PDF document and can be downloaded
  <a href="Robert_Knapp_CV.pdf">here</a>.</p>
  </div>
  <div class="statimg"> <img src="bknapp2.jpg"> Karsh photo 1985</div>
  <div class="statimg"> <img src="surgery.jpg"> Drs. Knapp and Goodman at surgery</div>
  <div class="statimg"> <img src="Bob-and-fellows.jpg"> Dr. Knapp's Fellows at retirement dinner 1993</div>
</div>
<div id="header">
<h2>Robert C. Knapp, MD</h2>
<ul>
  <li>William H. Baker Professor of Gynecology, Emeritus, Harvard Medical School</li>
  <li>Visiting Scholar in Obstetrics and Gynecology, Weill Medical College of
    Cornell University</li>
</ul>
</div>
<div class="honors">
<h3>Research Contributions</h3>
  <h4>Acute Renal Failure in Pregnancy and Septic Abortion</h4>
  <p>When I was a resident, I witnessed the appalling death rate from overwhelming
    sepsis caused by illegally induced abortions. I published two papers
    on the management of this problem in 1959 and 1960.<sup>1-2</sup></p>
  <h3><em>Ovarian Cancer Research</em></h3>
<h4>The surgical evaluation of aortic lymph nodes</h4>
<p>The surgical evaluation of the aortic lymph nodes revealed the presence of metastasis in patients who were thought to have cancer confined to the ovary. <sup>3</sup> Finding tumor in lymph nodes will change stage and often treatment.</p>
<h4>Formation of Malignant Ascites in Ovarian Cancer</h4>
<p>We used a murine model
    that developed ovarian cancer and malignant ascites to assess the role of
  tumor implants in the diaphragmatic lymphatic channels. These implants contributes
    to the formation of malignant ascites.<sup>4-5</sup> </p>
<h4>CA 125</h4>
<p>The detection of an ovarian cancer antigen in the blood of patients with ovarian cancer lead to the development of an immunoassay. This test has become the standard of medical practice for evaluating a pelvic mass, monitoring a patient with ovarian cancer receiving chemotherapy and determining recurrence after the completion of therapy.<sup>6-16</sup></p>
<h4>Surgical Contribution</h4>
<p>I described the dissection of the paravesical and
    pararectal spaces in pelvic operations.<sup>17</sup> This has enabled the surgeon to
  simplify dissection
    of the pelvic retroperitoneal both in radical operations as well as benign
    surgery. This dissection is of value to prevent ureteral injury as well as
  visualization of the artery and veins.</p>
<h4>Research To Date</h4>
<p>Assess ovarian tumor markers that could lead to the early
      detection of ovarian cancer. Participate in early detection grants evaluating
      women at high risk for ovarian cancer. Serve as consultant to industry
  in evaluating a variety of tumor markers.<sup>18-20</sup></p>
</div>
<div class="honors">
  <h3>Lectures and Teaching</h3>
  <h4> Medical Students</h4>
  <p>I teach a session on ovarian cancer at the Weill Medical School of Cornell University. I also have a seminar session related to the patient doctor interaction. We discuss such topics as the importance of empathy, giving bad news, informed consent, truth, and the non-conforming patient.<sup>21</sup> </p>
  <h4>Physician Lectures</h4>
  <p>Lectures at medical rounds, medical conferences
          and hospital meetings. </p>
</div>
<div class="honors">
  <h3>Clinical Practice</h3>
  <p> In 1998 I relocated to New York City from Boston. I do not
      maintain a practice.</p>
</div>
<div id="pub">
<h3>Publications</h3>
<div>

    <p>Dr. Knapp has published 211 medical articles. He is one of the co-inventors
    of the blood test for ovarian cancer, CA125. Selected papers are as follows:</p>
  <ol>
    <li><strong>Knapp RC and Hellman LM</strong>: Acute renal failure in pregnancy.
      Am J Obstet &amp; Gynecol. 1959;78:570.
</li>
    <li><strong>Knapp RC, Platt MA and Douglas RG</strong>: Septic abortion:
      five year analysis at the	New York Hosptial. Obstet &amp; Gynecol. 1960;15:344. </li>
    <li><strong>Knapp RC and Friedman EA:</strong> Aortic lymph node metastases
      in early ovartian cancer. Am J Obstet &amp; Gynecol. 1974;119:1013.</li>
    <li><strong>Feldman GB, Knapp RC, Order SE and Hellman S:</strong> The role of lymphatic obstruction
      in the formation of ascites in a murine ovarian carcinoma. Cancer Res.
      1972;32:1663.</li>
    <li><strong>Feldman GB and Knapp RC:</strong> Lymphatic drainage of the peritoneal
      cavity and its significance in ovarian cancer. Am J Obstet &amp;<br>
      Gynecol. 1974;119:991.</li>
    <li><strong>Bast RC Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz
      RS, Leavitt T, Griffiths CT, Parker L, Zarawski VR and Knapp RC</strong>: A radioimmunoassay
      using a
      monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl
    J Med. 1983;309:883.  </li>
    <li><strong>Klug TL, Bast RC Jr, Niloff JM, Knapp RC, Zurawski VR Jr</strong>: A monoclonal
      antibody immunoradiometric assay for an antigenic determinant (CA 125)
    associated with human epithelial ovarian carcinomas. Cancer Res. 1984;44:1048.  </li>
    <li><strong>Niloff JM, Bast RC Jr, Schaetzl EM and Knapp RC</strong>: Predictive value of CA 125
      antigen at second-look procedures in ovarian cancer.
    Am J Obstet Gynecol. 1985;151:981.  </li>
    <li><strong>Berek JS, Knapp RC, Malkasian GD, Lavin PT, Hacker NF, Whitney C,
      Niloff JM, Bast RC Jr</strong>: CA 125 serum levels correlate with second-look operations among
    ovarian cancer patients: Obstet Gynecol. 1986;67:685.</li>
    <li> <strong>Niloff JM, Knapp RC, Lavin PT, Malkasian GD, Berek JS, Mortel R,
      Whitney C, Zurawski VR, Bast RC Jr</strong>: The CA 125 assay as a predicator of clinical recurrence
    in epithelial ovarian cancer. Am J Obstet Gynecol. 1986;155:56.  </li>
    <li><strong>Lavin PT, Knapp RC, Malkasian G, Whitney CW, Berek JC, Bast RC Jr</strong>: CA 125
      for the monitoring of ovarian carcinoma during primary therapy.
    Obstet Gynecol. 1987;69:223.</li>
    <li> <strong>Finkler NJ, Benacerraf B, Lavin PT, Wojciechowski C, Knapp RC</strong>: Comparison
      of serum CA 125, clinical impression and ultrasound in the preoperative evaluation
    of ovarian masses. Obstet Gynecol 1988;72:659.</li>
    <li> <strong>Malkasian GC, Knapp RC, Lavin PT, Zurawski VR, Podratz RC, Stanhope
      CR, Mortel R, Berek JS, Bast RC Jr, Ritts RE</strong>: Preoperative evaluation of serum CA 125
    levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination
    of
    benign from malignant disease. Am J Obstet Gynecol. 1988;159:341.</li>
    <li> <strong>Knapp RC, Lau CC</strong>: Monoclonal antibodies and radioimmunoconjugates: Keeping
    feasibility at center stage. In: J Clin Oncol 1990;8:1938.</li>
    <li> <strong>Mok Ch, Tsao SW, Knapp RC, Fishbaugh PM, Lau CC</strong>: Unifocal origin of
    advanced human epithelial ovarian cancers. Cancer Research 1992;52:5119.  </li>
    <li><strong>Einhorn N, Sj&ouml;vall K, Knapp RC, Schoenfeld DA, Hall P, Scully RE, Bast RC Jr,
      Zurawski VR Jr</strong>: Prospective evaluation of serum CA 125 radioimmunoassay
    levels for early detection of ovarian cancer:. Obstet Gynecol 1992;80:14. </li>
    <li><strong>Knapp RC, Donahue VC and Friedman EA</strong>: Dissection of
      paravesical and pararectal spaces in pelvic operations. Surg Gynecol &amp;
      Obstet. 1973;137:758. </li>
    <li><strong>Knapp RC</strong>: Reflections on ovarian cancer: A 33-year experience.
      Gynecol Oncol, 1994; 54:124.      </li>
    <li><strong>Skates SJ, Xu Feng-J i, Yin-Hua Y, Sjovall K, Einhorn N, YuChiao
        C, Bast RC Jr, Knapp RC</strong>: Toward an optimal algorithm for ovarian
        cancer screening with longitudinal tumor markers. Cancer, 1995; 76:2004. </li>
    <li><strong>Skates Sj, Menon IJ, MacDonald N, Rosenthal AN, Oram DH, Knapp
        RC, Jacobs IJ</strong>: Calculation of the risk of ovarian cancer from
        serial CA 125 values for preclinical detection in postmenopausal women.
        J Clin Oncol. 2003;
    21(10 Suppl):206.</li>
    <li><strong>Skates SJ, Triano R, Knapp RC</strong>: Longitudinal CA 125 Detection of sporadic
    papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 2003;13:693-696.</li>
    <li><strong>Chervenak FA, McCullough LB, Knapp RC, Caputo TA, Barber HRK</strong>: A clinically
      comprehensive ethical framework for offering &amp; recommending treatment
    of cancer before and during pregnancy. Cancer. 2004; 100: 215.</li>
  </ol>
</div>
</div>
</body>
</html>
